Missouri House Bill HB1523

Missouri 2022 Regular Session

• Introduced: 1/5/22
• Refer: 5/13/22

Caption

Criminalizes the disclosure of medical marijuana patients' information to unauthorized parties

Impact

If enacted, HB1523 will criminalize the unauthorized disclosure of personal information related to medical marijuana patients. Violating this provision will result in a class E felony, thereby establishing a serious legal implication for state agencies and employees who might consider disclosing such sensitive information. This change could lead to an increase in trust among patients seeking medical marijuana, as they would be assured of better protection regarding their personal data. Additionally, this bill aligns with a broader trend of privacy legislation aimed at protecting individuals in various sectors.

Summary

House Bill 1523 introduces significant amendments to chapter 191 of the Revised Statutes of Missouri by establishing a new provision aimed at protecting the confidentiality of medical marijuana patients. The bill specifically forbids state agencies from disclosing the personal information of individuals who have applied for or obtained qualifying patient identification cards or caregiver identification cards. This legislative move is designed to strengthen the privacy rights of medical marijuana patients, ensuring that their personal data is not shared with unauthorized third parties, including federal entities. The intent of the bill is to provide a safeguard for patients as they access medical marijuana, reinforcing their rights under Missouri's constitutional provisions related to this matter.

Contention

While the bill appears to be a positive step towards patient privacy, it could also spark debates regarding the balance between state law and federal regulations, particularly in light of ongoing tensions over the legality of marijuana on a federal level. Some critics may argue that by restricting information sharing, the bill complicates matters for law enforcement and federal agencies that may seek access to such data for regulatory purposes. As a result, discussions surrounding HB1523 might focus on the implications of shielding patient information in the context of broader marijuana policy and enforcement practices.